One-hour paclitaxel plus carboplatin in the treatment of advanced non- small cell lung cancer: Results of a multicentre, phase II trial

European Journal of Cancer

Volumn 34, Issue 5, 1998, Pages 654-658

  Hainsworth, J D ^a   Urba, W J ^b   Hon, J K ^c   Thompson, K A ^d   Stagg, M P ^e   Hopkins, L G ^a   Thomas, M ^a   Greco, F A ^a  

^a Sarah Cannon Minnie Pearl Cancer C   (United States)

^b EARLE A CHILES RESEARCH INSTITUTE   (United States)

^c Comprehensive Cancer Institute ^*  (United States)

^d Montgomery Cancer Center   (United States)

^e MARY BIRD PERKINS CANCER CENTER   (United States)

Author keywords

Carboplatin; Chemotherapy; Non small cell lung cancer; Paclitaxel

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CLINICAL TRIAL; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME;

EID: 0032055240     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10103-4     Document Type: Article

References (13)

1. 1. Murphy WK, Fossella FV, Winn RJ, et al. Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 1993, 85, 384-388.
2. 2. Chang AY, Kim K, Glick J, et al Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer Inst 1993, 85, 388-394.
3. 3. Hainsworth JD, Thompson DS, Greco FA. Paclitaxel by 1-hour infusion: an active drug in metastatic non-small cell lung cancer. J Clin Oncol 1995, 13, 1609-1614.
4. 4. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995, 13, 1860-1870.
5. 5. Vafai D, Israel V, Zaretsky S, Natale RB. Phase I/II trial of combination carboplatin and Taxol in non-small cell lung cancer. Proc Am Soc Clin Oncol 1995, 14, 352 (Abstr.).
6. 6. Hainsworth JD, Greco FA. Paclitaxel administered by 1-hour infusion: preliminary results of a phase I/II trial comparing two schedules. Cancer 1994, 74, 1377-1382.
7. 7. Hainsworth JD, Raefsky EL, Greco FA. Paclitaxel administered by a 1-hour infusion: a phase I-II trial comparing two schedules. Cancer J Sci Am 1995, 1, 281-287.
8. 8. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
9. 9. Langer C, Kaplan R, Roswald E, et al Paclitaxel by 1-hour infusion combined with carboplatin in advanced non-small cell lung carcinoma (NSCLC): a phase II study. Proc Am Soc Clin Oncol 1996, 15, 396 (Abstr.).
10. 10. Schutte W, Bork I, Sucker S. Phase II trial of paclitaxel and carboplatin as firstline treatment in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1996 15, 398 (Abstr.).
11. 11. Ros V, Conner A, Mitchell RB. Carboplatin and paclitaxel for chemotherapy-naive patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1996, 15, 404 (Abstr.).
12. 12. Johnson DH, Paul DM, Hande KR, et al. Paclitaxel plus carboplatin in advanced non-small cell lung cancer: a phase II trial. J Clin Oncol 1996, 14, 2054-2060.
13. 13. Bonomi P, Kim K, Chang A, et al. Phase III trial comparing etoposide (E) cisplatin (C) versus taxol (T) with cisplatin-GCSF (G) versus taxol-cisplatin in advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group trial. Proc Am Soc Clin Oncol 1996, 15, 382 (Abstr.).